The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

BIOG BIOTECH GROWTH TRUST (THE) PLC ORD 25P



Income Statement  (£ m) 31-Mar-11 31-Mar-12 31-Mar-13 31-Mar-14 31-Mar-15
Continuing Operations
Revenue  n/a n/a n/a n/a n/a
Operating Profit/(Loss)  n/a n/a n/a n/a n/a
Net Interest  n/a n/a n/a n/a n/a
Profit Before Tax  n/a n/a n/a n/a n/a
Profit After Tax  -0.34 -0.31 -0.05 -0.09 0.12
Discontinued Operations
Profit After Tax  n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD  -0.34 -0.31 -0.05 -0.09 0.12
Attributable to:
Minority Interests  n/a n/a n/a n/a n/a
Equity Holders of Parent Company  -0.34 -0.31 -0.05 -0.09 0.12
 
Continuing EPS
Earnings per Share - Basic  -0.50p -0.50p -0.10p -0.10p 0.20p
Earnings per Share - Diluted  -0.50p -0.50p -0.10p -0.10p 0.20p
Earnings per Share - Adjusted  -0.50p -0.50p -0.10p -0.10p 0.20p
Continuing and Discontinued EPS
Earnings per Share - Basic  n/a n/a n/a n/a n/a
Earnings per Share - Diluted  n/a n/a n/a n/a n/a
Earnings per Share - Adjusted  n/a n/a n/a n/a n/a
 
Dividend per Share  0.00p 0.00p 0.00p 0.00p 0.00p

Balance Sheet  (£ m) 31-Mar-11 31-Mar-12 31-Mar-13 31-Mar-14 31-Mar-15
Assets
Non-Current Assets
Property, Plant & Equipment  n/a n/a n/a n/a n/a
Intangible Assets  n/a n/a n/a n/a n/a
Investment Properties  n/a n/a n/a n/a n/a
Investments  128.35 161.66 244.30 368.36 583.21
Other Financial Assets  n/a n/a n/a n/a n/a
Other Non-Current Assets  0.00 0.00 0.00 0.00 0.00
  128.35 161.66 244.30 368.36 583.21
Current Assets
Inventories  n/a n/a n/a n/a n/a
Trade & Other Receivables  1.16 0.21 13.97 12.07 3.33
Cash at Bank & in Hand  5.69 0.00 8.40 0.00 0.00
Current Asset Investments  0.00 0.00 0.00 0.00 0.00
Other Current Assets  n/a n/a n/a n/a n/a
  6.85 0.21 22.37 12.07 3.33
 
Total Assets  135.20 161.87 266.66 380.43 586.53
 
Liabilities
Current Liabilities
Borrowings  n/a n/a n/a n/a n/a
Other Current Liabilities  n/a n/a n/a n/a n/a
  14.380 5.737 27.048 40.186 53.232
 
Net Current Assets  -7.53 -5.52 -4.68 -28.11 -49.91
 
Non-Current Liabilities
Borrowings  n/a n/a n/a n/a n/a
Provisions  n/a n/a n/a n/a n/a
Other Non-Current Liabilities  n/a n/a n/a n/a n/a
  0.00 0.00 0.00 0.00 0.00
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  14.38 5.74 27.05 40.19 53.23
 
Net Assets  120.82 156.13 239.62 340.25 533.30
 
Capital & Reserves
Share Capital  120.82 156.13 239.62 340.25 533.30
Share Premium Account  n/a n/a n/a n/a n/a
Other Reserves  n/a n/a n/a n/a n/a
Retained Earnings  n/a n/a n/a n/a n/a
Shareholders Funds  120.82 156.13 239.62 340.25 533.30
 
Minority Interests/Other Equity  n/a n/a n/a n/a n/a
Total Equity  120.82 156.13 239.62 340.25 533.30

Ratios - based on IFRS 31-Mar-11 31-Mar-12 31-Mar-13 31-Mar-14 31-Mar-15
Continuing Operations
PE Ratio - Adjusted  -332.00 -472.00 -3680.00 -4670.00 3967.50
PEG - Adjusted  n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted  n/a n/a n/a n/a n/a
Dividend Cover  n/a n/a n/a n/a n/a
Revenue Per Share  n/a n/a n/a n/a n/a
Pre-Tax Profit per Share  n/a n/a n/a n/a n/a
Operating Margin  n/a n/a n/a n/a n/a
Return on Capital Employed  n/a n/a n/a n/a n/a
 
Continuing & Discontinued Operations
Dividend Yield  0.00% 0.00% 0.00% 0.00% 0.00%
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  186.00p 250.85p 371.69p 498.72p 834.73p
Net Gearing  n/a n/a n/a n/a n/a

Data is provided by Morningstar

Market

Company Information
Updated Monthly
Company address 25 Southampton Buildings, London, WC2A 1AL, United Kingdom
Company website http://www.biotechgt.co...
Market cap(in millions)* £ 526.17
Listing/Admission to trading 23 Jun 1997
Trading service -
Market -
Listing category Premium Equity Closed Ended Investment Funds
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
05-Jul-15
FTSE index FTSE All-Share,FTSE SmallCap
FTSE sector Equity Investment Instruments
FTSE sub-sector Equity Investment Instruments
Country of share register -
Segment -
MiFID Status -
Exchange market size -
SEDOL -
ISIN number -



BIOTECH GWTH share - fundamentals